ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL.

Poorvi H Dua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.